// App-Quantinova.ai

: IS SAFEHEART ‘SAFE’ TO EXTEND TO OTHER POPULATIONS?: ASSESSMENT OF SAFEHEART RISK PREDICTION MODEL EXTERNAL VALIDITY AMONG AN ENGLISH COHORT OF ROUTINE FAMILIAL HYPERCHOLESTEROLAEMIA PARTICIPANTS

Researchers

Presenter

  • Laura H. Gunn

Principal Investigators

  • Ailsa McKay

  • Kosh Ray

Medical Centers

  • Imperial College, London, United Kingdom

  • University of North Carolina at Charlotte, Charlotte, NC

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Cardiovascular (CVS)

  • Genetic Disorder

Disease

  • Hypercholesterolemia, Familial, 1

  • Myocardial infarction

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved